Search filters

List of works by Nobuhisa Ueda

A case of late-onset Tourette's disorder successfully treated with aripiprazole: view from blood levels of catecholamine metabolites and brain-derived neurotrophic factor (BDNF).

scientific article published in January 2009

A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder

scientific article published in January 2009

A close correlation between plasma and serum levels of brain-derived neurotrophic factor (BDNF) in healthy volunteers

scientific article

Acute risperidone treatment did not increase daily cigarette consumption or plasma levels of cotinine and caffeine: a pilot study

scientific article

Adding a low dose atypical antipsychotic drug to an antidepressant induced a rapid increase of plasma brain-derived neurotrophic factor levels in patients with treatment-resistant depression

scientific article published on 11 December 2009

Addition of risperidone to sertraline improves sertraline-resistant refractory depression without influencing plasma concentrations of sertraline and desmethylsertraline

scientific article

An open study of risperidone liquid in the acute phase of schizophrenia

scientific article published in June 2005

Association between plasma nitric oxide metabolites levels and negative symptoms of schizophrenia: a pilot study

scientific article published in March 2010

Associations between baseline plasma MHPG (3-methoxy-4-hydroxyphenylglycol) levels and clinical responses with respect to milnacipran versus paroxetine treatment

scientific article

Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and negative symptoms or cognitive impairments in early-stage schizophrenia

scientific article published in December 2009

Blood levels of brain-derived neurotrophic factor (BDNF) in major depressive disorder

scientific article published on January 2010

Brain-derived neurotrophic factor (BDNF) and mood disorder

scientific article published on November 2010

Changes in plasma monoamine metabolites during acute lithium intoxication

scientific article published on 01 July 2000

Clinical response to antidepressant treatment and 3-methoxy-4-hydroxyphenylglycol levels: mini review

scientific article published in July 2004

Continuous decrease in serum brain-derived neurotrophic factor (BDNF) levels in a neuropsychiatric syndrome of systemic lupus erythematosus patient with organic brain changes

scientific article published on December 2008

Critical examination of a correlation between brain gamma-aminobutyric acid (GABA) concentrations and a personality trait of extroversion in healthy volunteers as measured by a 3 Tesla proton magnetic resonance spectroscopy study

scientific article published on 12 March 2010

Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients

scientific article published in March 2010

Effect of risperidone on plasma catecholamine metabolites and brain-derived neurotrophic factor in patients with bipolar disorders

scientific article published in October 2006

Effects of acute paroxetine treatment on the consumption of cigarette smoking and caffeine in depressed patients

scientific article published on 01 October 2007

Effects of antidepressants on plasma metabolites of nitric oxide in major depressive disorder: comparison between milnacipran and paroxetine

scientific article published on 5 August 2009

Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients

scientific article

Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: a pilot study

scientific article

Fluctuating plasma levels of the active moiety of risperidone is related to occurrence of extrapyramidal symptoms

scientific article published on 01 January 2009

Grapefruit juice alters plasma sertraline levels after single ingestion of sertraline in healthy volunteers

scientific article published in January 2009

Grapefruit juice-fluvoxamine interaction--is it risky or not?

scientific article (publication date: August 2003)

Higher plasma 5-hydroxyindoleacetic acid levels are associated with SSRI-induced nausea

scientific article published in January 2003

Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression

scientific article published on 28 March 2009

Increase of plasma brain-derived neurotrophic factor levels in two psychotic depressed patients responding to lithium addition to paroxetine treatment.

scientific article published on January 2007

Interaction between fluvoxamine and cotinine or caffeine

scientific article published in January 2002

Long-term effect of efavirenz autoinduction on plasma/peripheral blood mononuclear cell drug exposure and CD4 count is influenced by UGT2B7 and CYP2B6 genotypes among HIV patients

scientific article published on 16 August 2011

No difference in adherence to paroxetine between depressed patients with early remission and those with late remission based on monitoring of plasma paroxetine concentrations ⬇️

scientific article published on August 1, 2010

Nonadherence to paroxetine: a study based on monitoring plasma paroxetine levels

scientific article published in February 2010

Olanzapine orally disintegrating tablets (Zyprexa Zydis) rapidly improve excitement components in the acute phase of first-episode schizophrenic patients: an open-label prospective study

scientific article published on January 2009

Pharmacogenetic & pharmacokinetic biomarker for efavirenz based ARV and rifampicin based anti-TB drug induced liver injury in TB-HIV infected patients

scientific article

Plasma levels of homovanillic acid and the response to risperidone in first episode untreated acute schizophrenia

scientific article published in March 2003

Possible relationships between plasma carbamazepine-10,11-epoxide levels and antimanic efficacy and side effects in patients with schizoaffective disorde

scientific article published on 01 June 2000

Prediction of response to risperidone treatment with respect to plasma concencentrations of risperidone, catecholamine metabolites, and polymorphism of cytochrome P450 2D6.

scientific article

Predictive factors for responding to sertraline treatment: views from plasma catecholamine metabolites and serotonin transporter polymorphism

scientific article published on 13 October 2009

Rapid response to paroxetine is associated with plasma paroxetine levels at 4 but not 8 weeks of treatment, and is independent of serotonin transporter promoter polymorphism in Japanese depressed patients.

scientific article published in August 2009

Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T Proton MRS study.

scientific article

Relationships between stress, social adaptation, personality traits, brain-derived neurotrophic factor and 3-methoxy-4-hydroxyphenylglycol plasma concentrations in employees at a publishing company in Japan ⬇️

scientific article published on September 15, 2010

Reliability, validity and clinical utility of a Japanese version of the Social Adaptation Self‐evaluation Scale as calibrated using the Beck Depression Inventory ⬇️

scientific article published on December 1, 2011

Risperidone in the treatment of psychotic depression

scientific article published on 06 March 2006

Serum brain-derived neurotrophic factor levels as a novel biological marker for the activities of psychiatric symptoms in systemic lupus erythematosus

scientific article published in March 2010

Serum levels of brain-derived neurotrophic factor in comorbidity of depression and alcohol dependence.

scientific article published in July 2009

Stress at work alters serum brain-derived neurotrophic factor (BDNF) levels and plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) levels in healthy volunteers: BDNF and MHPG as possible biological markers of mental stress?

scientific article published on 17 November 2007

Therapeutic drug monitoring of plasma fluvoxamine levels for treating bulimia nervosa

scientific article published on 01 August 2007

Three polymorphisms of the eNOS gene and plasma levels of metabolites of nitric oxide in depressed Japanese patients: a preliminary report

scientific article published in October 2011

Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients

scientific article

Trichotilliomania responding to low-dose fluvoxamine

scientific article published in October 2009

Two cases of burning mouth syndrome treated with olanzapine

scientific article published in June 2008

[Therapeutic effectiveness of transcranial magnetic stimulation for intractable depressive disorders-- blood catecholamines and BDNF]

scientific article published on 01 January 2007

Paulina is supported by:

About Paulina

Help